A
Apogee Therapeutics Inc
NASDAQ:APGE
Apogee Therapeutics Inc
NASDAQ:APGE
Price:
90.9
USD
7.97%
Market Closed
Market Cap:
$6.9B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
A
|
Apogee Therapeutics Inc
NASDAQ:APGE
|
US |
|
H
|
Hewlett Packard Enterprise Co
XETRA:2HP
|
US |
|
Basic Fit NV
F:B4F
|
NL |
|
Smith & Nephew PLC
LSE:SN
|
UK |
|
H
|
Hershey Co
F:HSY
|
US |
|
E
|
Eco World International Bhd
KLSE:EWINT
|
MY |
|
C
|
Clinuvel Pharmaceuticals Ltd
OTC:CLVLY
|
AU |
|
Horizon Gold Ltd
ASX:HRN
|
AU |
Wall St Price Targets
APGE Price Targets Summary
Apogee Therapeutics Inc
Apogee Therapeutics Inc
Wall Street analysts forecast APGE stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for APGE is 120.74 USD with a low forecast of 82.82 USD and a high forecast of 168 USD.
Lowest Forecast
Price Target
82.82
USD
9% Downside
Average Forecast
Price Target
120.74
USD
33% Upside
Highest Forecast
Price Target
168
USD
85% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is APGE's stock price target?
Price Target
120.74
USD
120.74
USD
According to Wall Street analysts, the average 1-year price target for APGE is 120.74 USD with a low forecast of 82.82 USD and a high forecast of 168 USD.
